Localization of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus-infected mouse eyes

Investigative Ophthalmology and Visual Science

Volumn 38, Issue 1, 1997, Pages 9-15

  Cunningham Jr , Emmett T ^a,b   Stalder, Anna ^c   Sanna, Pietro Paolo ^c   Liu, Stephanie S ^a   Bloom, Floyd E ^c   Howes Jr , Edward L ^b   Campbell, Iain L ^c   Margolis, Todd P ^a,b,d  

^a Francis I Proctor Foundation   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

choroid; iris; receptor; tumor necrosis factor; uveitis

Indexed keywords

COMPLEMENTARY RNA; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD EYE BARRIER; CONTROLLED STUDY; EYE INFECTION; EYE INFLAMMATION; HERPES SIMPLEX VIRUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA PROBE; UVEA; VIRUS INFECTION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; AUTORADIOGRAPHY; EYE; FEMALE; IN SITU HYBRIDIZATION; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, MESSENGER; SIMPLEXVIRUS;

EID: 1842328053     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Beutler B. TNF, immunity and inflammatory disease: Lessons of the past decade. J Invest Med. 1995;43:227-235.
2. Tracey K, Cerami A. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Ann Rev Med. 1994;45:491-503.
3. Fiers W. Tumor necrosis factor: Characterization at the molecular, cellular and in vivo level. FEBS Lett. 1991;285:199-212.
4. Kulkarni PS, Srinivasan BD. Cachectin: A novel polypeptide induces uveitis in the rabbit eye. Exp Eye Res. 1988;46:631-633.
5. Rosenbaum JT, Howes EL Jr, Rubin RM, Samples JR. Ocular inflammatory effects of intravitreally injected tumor necrosis factor. Am J Pathol. 1988;133:47-53.
6. Fleisher LN, Ferrell JB, McGahan MC. Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin. Inflammation. 1990;14:325-335.
7. Fleisher LN, Ferrell JB, Smith MG, McGahan MC. Lipid mediators of tumor necrosis factor-alpha-induced uveitis. Invest Ophthalmol Vis Sci. 1991;32:2393-2399.
8. De Vos AF, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res. 1992;11:581-597.
9. Tamihara H, Yoshida M, Yoshimura N. Tumor necrosis factor-α gene is expressed in stimulated retinal pigment epithelial cells in culture. Biochem Biophys Res Commun. 1992;187:1029-1034.
10. de Kozak Y, Goureau O, Bellot J, Naud MC, Faure JP, Hicks D. Tumor necrosis factor synthesis by resident retinal cells from uveitis-susceptible and resistant rat strains: Synthesis and regulation of nitric oxide from Lewis rat retinal Muller cells. In: Nussenblatt RB, Whitcup SM, Caspi RR, Gery I, eds. Advances in Ocular Immunology. New York: Elsevier; 1994:3-6.
11. Chandrasekharam NN, Detrick B, Hooks JJ. Human retinal pigment epithelial cells secrete cytokines in response to inflammatory mediates. In: Nussenblatt RB, Whitcup SM, Caspi RR, Gery I, eds. Advances in Ocular Immunology. New York: Elsevier; 1994:17-20.
12. Planck SR, Huang X-N, Robertson JE, Rosenbaum JT. Cytokine mRNA levels in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci. 1994;35:924-930.
13. Rosenbaum JT, Boney RS. Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor. Reg Immunol. 1993;5:299-303.
14. Nakamura S, Yamakawa T, Sugita M, et al. The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci. 1994;35:3884-3889.
15. Ferguson TA, Herndon JM, Dube P. The immune response and the eye: A role for TNFα in anterior chamber-associated immune deviation. Invest Ophthalmol Vis Sci. 1994;35:2643-2651.
16. Franks WA, Limb GA, Stanford MR, et al. Cytokines in human intraocular inflammation. Curr Eye Res. 1992;11:187-191.
17. Nolle B, Gordes RS, Wiechens B. Small amounts of TNF-α in vitreous specimens of patients with intermediate uveitis. In: Nussenblatt RB, Whitcup SM, Caspi RR, Gery I, eds. Advances in Ocular Immunology. New York: Elsevier; 1994:361-364.
18. Rahi AH, Al-Kaff A, Rahi SL, Rahi JS. Cytokine profile in uveitis: A point prevalence study. In: Nussenblatt RB, Whitcup SM, Caspi RR, Gery I, eds. Advances in Ocular Immunology. New York: Elsevier; 1994:369-372.
19. Leibovich JS, Poiverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 1987;329:630-632.
20. Einer VM, Stricter RM, Pavilack MA, et al. Human corneal interleukin-8: IL-1 and TNF-induced gene expression and secretion. Am J Pathol. 1991;139:977-988.
21. Strieter RM, Kunkel SL, Einer VM, et al. Interleukin-8: A corneal factor that induces neovascularization. Am J Pathol 1992;141:1279-1284.
22. Burke JM. Stimulation of DNA synthesis in human and bovine RPE by peptide growth factors: The response to TNF-alpha and EGF is dependent upon culture density. Curr Eye Res. 1989;8:1279-1286.
23. Limb GA, Little BC, Meager A, et al. Cytokines in proliferative vitreoretinopathy. Eye. 1994;5:686-693.
24. Limb GA, Earley O, Jones SE, LeRoy F, Chignell AH, Dumonde DC. Expression of mRNA coding for TNFα, IL-1β and IL-6 by cells infiltrating retinal membranes. Graefe's Arch Clin Exp Ophthalmol. 1994;232:646-651.
25. Hofman FM, Hinton DR, Johnson K, Merril JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med. 1989;170:607-612.
26. Selmaj K, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest. 1991;87:949-954.
27. Sharief MK, Hentges R. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med. 1991;325:467-472.
28. Powell MB, Mitchell D, Lederman J, et al. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int Immunol. 1990;2:540-544.
29. Goodwin RG, Anderson D, Jerzy R, et al. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol Cell Biol. 1991;11:3020-3026.
30. Loetscher H, Steinmetz M, Lessiauer W. Tumor necrosis factor: Receptors and inhibitors. Cancer Cells. 1991;3:221-226.
31. Tartaglia LA, Rothe M, Hu Y-F, Goeddel DV. Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell 1993;73:213-216.
32. Sippy BD, Hofman FM, He S, et al. SV40-immortalized and primary cultured human retinal pigment epithelial cells share similar pattarns of cytokine-receptor expression and cytokine responsiveness. Curr Eye Res. 1995;14:495-503.
33. Cunningham ET Jr, De Souza EB. Localization of type I IL-1 receptor mRNA in brain and endocrine tissues using in situ hybridization histochemistry. In: De Souza EB, ed. Methods in Neuroscience. Neurobiology of Cytokines, Part A. New York: CRC Press; 1994:112-127.
34. Feduchi E, Alonso MA, Carrasco L. Human gamma interferon and tumor necrosis factor exert a synergistic blockage on the replication of herpes simplex virus. J Virol. 1989;63:398-409.
35. Rossol-Voth R, Rossol S, Schutt KH, Corridori S, de Cian W, Falke D. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J Gen Virol. 1991;72:143-147.
36. Shun-Hua C, Oakes JE, Lausch RN. Synergistic antiherpes effect of TNF-a and IFN-g in human corneal epithelial cells with that in corneal fibroblasts. Antiviral Res. 1994;25:201-213.
37. Gashi H, Wechsler SL, Kaiwar R, Nesburn AB, Hofman FM. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal acarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J Virol. 1995;69:334-340.
38. Stalder A, Campbell IL. Cytokine receptor gene expression in lymphocytic choriomeningitis. Soc Neurosci Abstrs. 1993;326.
39. Campbell IL, Hobbs MV, Kemper P, Oldstone MBA. Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J Immunol. 1994;152:716-723.
40. Shimeld C, Whiteland JL, Nicholls SM, et al. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol. 1995;61:7-16.
41. Stalder A, Campbell IL. Simultaneous detection of multiple cytokine receptor mRNAs by RNase protection assay in LPS-induced endotoxiemia. Lymphokine Cytokine Res. 1994;13:107-109.
42. Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W. Tumor necrosis factor alpha (TNF alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med. 1993;177:1277-1286.
43. Slowik MR, De Luca LG, Fiers W, Pober JS. Tumor necrosis factor activates human endothelium cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentrations. Am J Pathol. 1993;143:1724-1730.
44. Tran MT, Tellaetxe-Isusi M, Elner V, Strieter RM, Lausch RN, Oakes JE. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells: β-chemokine synthesis in corneal cells. Invest Ophthatmol Vis Sci. 1996;37:987-996.